Upgrade to SI Premium - Free Trial

Citi Starts Mirum Pharmaceuticals (MIRM) at Buy

June 2, 2026 5:01 AM
Citi analyst Yigal Nochomovitz initiates coverage on Mirum Pharmaceuticals (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hot New Coverage New Coverage